Expiratory Muscle Conditioning in Multiple Sclerosis Using Magnetic Stimulation
Multiple Sclerosis

About this trial
This is an interventional treatment trial for Multiple Sclerosis focused on measuring Multiple Sclerosis, Functional Magnetic Stimulation, Pulmonary Function
Eligibility Criteria
Inclusion Criteria:
- Multiple Sclerosis diagnosis
- Baseline maximal expiratory pressure (MEP) values between 50% and 70% of predicted values
- Patients must also be in stable condition and free of active brain disease or cardiovascular disorders (history of myocardial infarction, congestive heart disease, or uncontrolled hypertension).
Exclusion Criteria:
- Cardiac pacemakers, ferromagnetic metal implants, uncontrolled high blood pressure, active pulmonary conditions such as chronic obstructive pulmonary disease, bronchiectasis, asthma, and diaphragmatic paralysis.
- Patients who are ventilator dependent, with significant scoliosis, other chest wall deformity, obesity, severe diabetes mellitus, as well as pregnant women will be excluded from participating in the study.
- Patients with substance abuse or mental incompetence will also be excluded.
Sites / Locations
- Cleveland Clinic
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Functional Magnetic Stimulation
Resistive Expiratory Muscle Training
This group will receive magnetic stimulation of the respiratory (breathing) muscles that may improve the breathing function in subjects with MS. The magnetic stimulation protocol (plan of study) consists of a daily expiratory (breathing out) muscle conditioning program (20 minutes).
Participants in this group will perform breathing exercises using a resistive breathing device. The training will take place in the FMS lab. After training, participants will perform the exercise for 20 minutes daily (5days each week for 6 weeks) in their home.